REX AMERICAN RESOURCES CORP (REX) Fundamental Analysis & Valuation

NYSE:REX • US7616241052

39.55 USD
-0.11 (-0.28%)
At close: Mar 12, 2026
39.5 USD
-0.05 (-0.13%)
After Hours: 3/12/2026, 8:08:24 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This REX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall REX gets a fundamental rating of 6 out of 10. We evaluated REX against 207 industry peers in the Oil, Gas & Consumable Fuels industry. REX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. REX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. REX Profitability Analysis

1.1 Basic Checks

  • In the past year REX was profitable.
  • In the past year REX had a positive cash flow from operations.
  • In the past 5 years REX has always been profitable.
  • REX had a positive operating cash flow in each of the past 5 years.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M 100M

1.2 Ratios

  • REX has a Return On Assets of 6.71%. This is in the better half of the industry: REX outperforms 75.36% of its industry peers.
  • REX has a Return On Equity of 8.87%. This is comparable to the rest of the industry: REX outperforms 54.11% of its industry peers.
  • With a Return On Invested Capital value of 6.21%, REX perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for REX is significantly below the industry average of 22.51%.
Industry RankSector Rank
ROA 6.71%
ROE 8.87%
ROIC 6.21%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • REX has a Profit Margin (7.73%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of REX has grown nicely.
  • With a Operating Margin value of 8.58%, REX is not doing good in the industry: 60.39% of the companies in the same industry are doing better.
  • REX's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 12.66%, REX is not doing good in the industry: 68.60% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of REX has grown nicely.
Industry RankSector Rank
OM 8.58%
PM (TTM) 7.73%
GM 12.66%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. REX Health Analysis

2.1 Basic Checks

  • REX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for REX has been reduced compared to 1 year ago.
  • REX has less shares outstanding than it did 5 years ago.
  • REX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 7.02 indicates that REX is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of REX (7.02) is better than 91.30% of its industry peers.
  • The Debt to FCF ratio of REX is 0.19, which is an excellent value as it means it would take REX, only 0.19 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of REX (0.19) is better than 90.34% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that REX is not too dependend on debt financing.
  • REX's Debt to Equity ratio of 0.00 is amongst the best of the industry. REX outperforms 83.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.19
Altman-Z 7.02
ROIC/WACC0.7
WACC8.85%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • REX has a Current Ratio of 7.16. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
  • REX has a Current ratio of 7.16. This is amongst the best in the industry. REX outperforms 90.82% of its industry peers.
  • A Quick Ratio of 6.68 indicates that REX has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 6.68, REX belongs to the top of the industry, outperforming 90.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.16
Quick Ratio 6.68
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. REX Growth Analysis

3.1 Past

  • REX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.19%.
  • Measured over the past years, REX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.01% on average per year.
  • REX shows a decrease in Revenue. In the last year, the revenue decreased by -3.14%.
  • Measured over the past years, REX shows a quite strong growth in Revenue. The Revenue has been growing by 8.99% on average per year.
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y51.01%
EPS Q2Q%2.81%
Revenue 1Y (TTM)-3.14%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%0.43%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.72% on average over the next years. This is a very strong growth
  • REX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.00% yearly.
EPS Next Y-4.83%
EPS Next 2Y35.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

4

4. REX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.97, the valuation of REX can be described as rather expensive.
  • REX's Price/Earnings ratio is in line with the industry average.
  • REX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.71.
  • Based on the Price/Forward Earnings ratio of 13.05, the valuation of REX can be described as correct.
  • REX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. REX is cheaper than 73.91% of the companies in the same industry.
  • REX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 23.97
Fwd PE 13.05
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as REX.
  • REX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 74.06
EV/EBITDA 13.77
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • REX's earnings are expected to grow with 35.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.47
EPS Next 2Y35.72%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. REX Dividend Analysis

5.1 Amount

  • No dividends for REX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

REX Fundamentals: All Metrics, Ratios and Statistics

REX AMERICAN RESOURCES CORP

NYSE:REX (3/12/2026, 8:08:24 PM)

After market: 39.5 -0.05 (-0.13%)

39.55

-0.11 (-0.28%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)12-01
Earnings (Next)05-26
Inst Owners82.54%
Inst Owner Change0.94%
Ins Owners16.59%
Ins Owner Change2.85%
Market Cap1.30B
Revenue(TTM)650.76M
Net Income(TTM)50.30M
Analysts80
Price TargetN/A
Short Float %2.52%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.25%
Min Revenue beat(2)-4.71%
Max Revenue beat(2)-1.78%
Revenue beat(4)1
Avg Revenue beat(4)-1.48%
Min Revenue beat(4)-4.71%
Max Revenue beat(4)3.38%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)1.42%
Revenue beat(16)8
Avg Revenue beat(16)1.61%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 23.97
Fwd PE 13.05
P/S 2
P/FCF 74.06
P/OCF 14.62
P/B 2.3
P/tB 2.3
EV/EBITDA 13.77
EPS(TTM)1.65
EY4.17%
EPS(NY)3.03
Fwd EY7.66%
FCF(TTM)0.53
FCFY1.35%
OCF(TTM)2.71
OCFY6.84%
SpS19.76
BVpS17.21
TBVpS17.21
PEG (NY)N/A
PEG (5Y)0.47
Graham Number25.28
Profitability
Industry RankSector Rank
ROA 6.71%
ROE 8.87%
ROCE 8.06%
ROIC 6.21%
ROICexc 12.05%
ROICexgc 12.05%
OM 8.58%
PM (TTM) 7.73%
GM 12.66%
FCFM 2.7%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
ROICexc(3y)16.25%
ROICexc(5y)14.31%
ROICexgc(3y)16.25%
ROICexgc(5y)14.31%
ROCE(3y)8.77%
ROCE(5y)8.17%
ROICexgc growth 3Y-10.04%
ROICexgc growth 5Y127.29%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y127.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
F-Score3
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.19
Debt/EBITDA 0.04
Cap/Depr 693.99%
Cap/Sales 10.99%
Interest Coverage 250
Cash Conversion 134.76%
Profit Quality 34.97%
Current Ratio 7.16
Quick Ratio 6.68
Altman-Z 7.02
F-Score3
WACC8.85%
ROIC/WACC0.7
Cap/Depr(3y)248.7%
Cap/Depr(5y)164.84%
Cap/Sales(3y)5.81%
Cap/Sales(5y)4.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y51.01%
EPS Q2Q%2.81%
EPS Next Y-4.83%
EPS Next 2Y35.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.14%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%0.43%
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.49%
EBIT growth 3Y-2.54%
EBIT growth 5Y134.95%
EBIT Next Year3.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.09%
OCF growth 3Y-11.21%
OCF growth 5Y44.19%

REX AMERICAN RESOURCES CORP / REX FAQ

What is the fundamental rating for REX stock?

ChartMill assigns a fundamental rating of 6 / 10 to REX.


What is the valuation status of REX AMERICAN RESOURCES CORP (REX) stock?

ChartMill assigns a valuation rating of 4 / 10 to REX AMERICAN RESOURCES CORP (REX). This can be considered as Fairly Valued.


How profitable is REX AMERICAN RESOURCES CORP (REX) stock?

REX AMERICAN RESOURCES CORP (REX) has a profitability rating of 5 / 10.


What is the valuation of REX AMERICAN RESOURCES CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for REX AMERICAN RESOURCES CORP (REX) is 23.97 and the Price/Book (PB) ratio is 2.3.


How financially healthy is REX AMERICAN RESOURCES CORP?

The financial health rating of REX AMERICAN RESOURCES CORP (REX) is 9 / 10.